Understanding the Mechanism of Action of Atypical Antipsychotic Drugs
Author:
- Jeffrey A. LiebermanJLJeffrey A. Lieberman
- 1 December 1993
- journal article
- review article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 163 (S22) , 7-18
Abstract
The thrust of development of new antipsychotic drugs has been to identify new compounds that have enhanced antipsychotic efficacy and have lesser side-effects than standard neuroleptic compounds. Drug development strategies no longer concentrate on D2receptor antagonism but aim to produce novel compounds. The following have been pursued: (a) selective dopamine receptor antagonists; (b) serotonin receptor agonists and antagonists (5-HT1a,e, 5-HT2, 5-HT3) or mixed 5-HT2- D2receptor antagonist; (c) selective dopamine agonists or partial agonists; and (d) sigma-site and excitatory amino-acid antagonists. Such compounds are at various stages of development. The only drug which has truly distinguished itself as ‘atypical’ is clozapine. Its mechanism of action is unknown and the search for it, in large part, has been the impetus for development of the compounds listed above.Keywords
This publication has 88 references indexed in Scilit:
- Pharmacologic properties of (?)-3PPP (preclamol) in manJournal of Neural Transmission, 1992
- Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsyJournal of Neural Transmission, 1991
- ClozapineDrugs, 1990
- Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patientsPsychopharmacology, 1989
- Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurologyGeneral Pharmacology: The Vascular System, 1988
- Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the ratJournal of Neural Transmission, 1987
- A Controlled Clinical Trial of Tiaspirone in SchizophreniaInternational Clinical Psychopharmacology, 1987
- Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivityJournal of Neural Transmission, 1985
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978
- ON THE RELEVANCE OF PREFERENTIAL INCREASES OF MESOLIMBIC VERSUS STRIATAL DOPAMINE TURNOVER FOR THE PREDICTION OF ANTIPSYCHOTIC ACTIVITY OF PSYCHOTROPIC DRUGSJournal of Neurochemistry, 1976